A 55-year-old woman with no ASCVD has LDL-C 110 mg/dL and 10-year ASCVD risk 9%. She declines statins. What nonstatin therapy has modest LDL-C lowerin...

Question

A 55-year-old woman with no ASCVD has LDL-C 110 mg/dL and 10-year ASCVD risk 9%. She declines statins. What nonstatin therapy has modest LDL-C lowering and outcome benefit when statins are not tolerated?

Accepted Answer

Ezetimibe

Answer

Niacin

Answer

Fenofibrate

Answer

Fish oil (EPA/DHA)

Answer

Bile acid sequestrant only

us-abfm MCQ (SBA): Primary prevention-statin intolerance

A 55-year-old woman with no ASCVD has LDL-C 110 mg/dL and 10-year ASCVD risk 9%. She declines statins. What nonstatin therapy has modest LDL-C lowering and outcome benefit when statins are not tolerated?